PSP Research LLC 13F Holdings · Q3 2026
PSP Research LLC reported 44 securities worth $145.83M in its SEC 13F filing for Q3 2026 (period ended 2026-09-30). Top holdings: SGOV (48.33%), XBI (41.79%), SERA (3.43%). Among its top 25 positions this quarter: 1 new, 16 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SGOV | ISHARES TR | $70.5M | 48.33% | 700,000 | Hold |
| 2 | XBI | SPDR SERIES TRUST | $60.9M | 41.79% | 386,500 | Trimmed |
| 3 | SERA | SERA PROGNOSTICS INC | $5.0M | 3.43% | 2.4M | New |
| 4 | HALO | HALOZYME THERAPEUTICS INC | $331,200 | 0.23% | 3,000 | Trimmed |
| 5 | MDGL | MADRIGAL PHARMACEUTICALS INC | $302,376 | 0.21% | 600 | Hold |
| 6 | ARGX | ARGENX SE | $287,673 | 0.20% | 300 | Trimmed |
| 7 | EXEL | EXELIXIS INC | $292,050 | 0.20% | 5,000 | Trimmed |
| 8 | NRIX | NURIX THERAPEUTICS INC | $284,520 | 0.20% | 12,000 | Trimmed |
| 9 | RPRX | ROYALTY PHARMA PLC | $291,800 | 0.20% | 5,000 | Trimmed |
| 10 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $274,820 | 0.19% | 7,000 | Trimmed |
| 11 | TARS | TARSUS PHARMACEUTICALS INC | $275,135 | 0.19% | 3,500 | Trimmed |
| 12 | TGTX | TG THERAPEUTICS INC | $278,900 | 0.19% | 5,000 | Trimmed |
| 13 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $264,300 | 0.18% | 10,000 | Trimmed |
| 14 | IMNM | IMMUNOME INC | $258,120 | 0.18% | 12,000 | Trimmed |
| 15 | KNSA | KINIKSA PHARMACEUTICALS INTL | $261,135 | 0.18% | 3,500 | Trimmed |
| 16 | NBIX | NEUROCRINE BIOSCIENCES INC | $255,312 | 0.18% | 1,800 | Trimmed |
| 17 | SUPN | SUPERNUS PHARMACEUTICALS | $258,240 | 0.18% | 6,000 | Hold |
| 18 | ALKS | ALKERMES PLC | $243,120 | 0.17% | 6,000 | Hold |
| 19 | AUPH | AURINIA PHARMACEUTICALS INC | $242,925 | 0.17% | 15,000 | Trimmed |
| 20 | DFTX | DEFINIUM THERAPEUTICS INC | $247,390 | 0.17% | 6,500 | Trimmed |
| 21 | INCY | INCYTE CORP | $242,700 | 0.17% | 2,000 | Trimmed |
| 22 | NTLA | INTELLIA THERAPEUTICS INC | $241,200 | 0.17% | 20,000 | Hold |
| 23 | ORKA | ORUKA THERAPEUTICS INC | $249,870 | 0.17% | 3,000 | Hold |
| 24 | RVMD | REVOLUTION MEDICINES INC | $246,312 | 0.17% | 1,200 | Hold |
| 25 | TNGX | TANGO THERAPEUTICS INC | $249,500 | 0.17% | 10,000 | Hold |
Source: SEC Form 13F filings · as of 2026-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR